It has been proposed that heterogeneity in natural killer (NK)–cell phenotype and function can be achieved through distinct thymic and bone marrow pathways of NK-cell development. Here, we show a link between Notch signaling and the generation of intracellular CD3ϵ (cyCD3)–expressing NK cells, a cell population that can be detected in vivo. Differentiation of human CD34+ cord blood progenitors in IL-15–supplemented fetal thymus organ culture or OP9-Delta-like 1 (DL1) coculture resulted in a high percentage of cyCD3+ NK cells that was blocked by the γ-secretase inhibitor DAPT. The requirement for Notch signaling to generate cyCD3+ NK cells was further illustrated by transduction of CD34+ cord blood (CB) cells with either the active intracellular part of Notch or the dominant-negative mutant of mastermind-like protein 1 that resulted in the generation of NK cells with respectively high or low frequencies of cyCD3. Human thymic CD34+ progenitor cells displayed the potential to generate cyCD3+ NK cells, even in the absence of Notch/DL1 signaling. Peripheral blood NK cells were unable to induce cyCD3 expression after DL1 exposure, indicating that Notch-dependent cyCD3 expression can only be achieved during the early phase of NK-cell differentiation.
No takes yet. Share an insight, caveat, or question.
Smedt et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: